Founded in 2009, JYMed is a leading peptide CRDMO service provider and generic API manufacturer in China specializing in the custom synthesis, process development, clinical supply and commercialization of peptide substances. The company employs approximately 600+ FTEs, with a core management team composed of experts with over 20 years of experience in peptide technology. JYMed operates one R&D center and two major multi-purpose production facilities, with multi-ton scale peptide manufacturing capacity.
As a customer-focused company, JYMed offers a comprehensive peptide development and industrialization platform backed by over 20 years of R&D expertise and state-of-the-art facilities. We deliver high-quality peptides tailored to each client’s needs.
JYMed provides a broad portfolio of over 20 peptide APIs, including Semaglutide, Tirzepatide, Liraglutide, Degarelix, and Oxytocin. Several of these, such as Semaglutide and Tirzepatide, have successfully completed registration and commercialization.
JYMed offers a comprehensive and efficient CDMO platform, providing full-spectrum services for peptide and peptide-analog products. This includes the research and production of therapeutic peptides, veterinary peptides, and more.
JYMed supplies high-quality cosmetic peptides, raw materials, and OEM formulations ranging from research to cGMP grade—all under strict quality control. Our synthetic peptides are widely valued for their safety, purity, and ease of customization.
JYMed is a US FDA-inspected peptide manufacturer specializing in cosmetic peptides, peptide APIs, and custom peptides. Our featured products include Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, and more. To learn more, please contact us at:
Email: jymed@jymedtech.com
We’re excited to join industry leaders at CPHI South East Asia 2025, happening from July 16 to 18 at MITEC in Kuala Lumpur. The event spans over 15,000 square meters and will feature around 400 exhibitors. More than 8,000 professionals are expected to attend, along with 60+ seminars and forums f...
From June 24 to 26, 2025, the 23rd CPhI China was successfully held at the Shanghai New International Expo Centre!JYMed President Mr. Yao Zhiyong, together with the company’s senior leadership team, attended the event in person. The team engaged directly with the full l...
We’re excited to announce that JYMed will be exhibiting at Interphex Week Tokyo from July 9 to 11, 2025, at Tokyo Big Sight (Ariake). This major event brings together over 90 exhibitors and approximately 34,000 professionals from across the pharmaceutical and cosmetics industries. As one of Asia’...